349 related articles for article (PubMed ID: 22404905)
1. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.
Laberge RM; Zhou L; Sarantos MR; Rodier F; Freund A; de Keizer PL; Liu S; Demaria M; Cong YS; Kapahi P; Desprez PY; Hughes RE; Campisi J
Aging Cell; 2012 Aug; 11(4):569-78. PubMed ID: 22404905
[TBL] [Abstract][Full Text] [Related]
2. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells.
Perrott KM; Wiley CD; Desprez PY; Campisi J
Geroscience; 2017 Apr; 39(2):161-173. PubMed ID: 28378188
[TBL] [Abstract][Full Text] [Related]
3. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes.
Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F
Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271
[TBL] [Abstract][Full Text] [Related]
4. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.
Orjalo AV; Bhaumik D; Gengler BK; Scott GK; Campisi J
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17031-6. PubMed ID: 19805069
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype.
Hou J; Cui C; Kim S; Sung C; Choi C
Chem Biol Interact; 2018 Mar; 283():75-83. PubMed ID: 29412148
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel senomorphic agent, avenanthramide C, via the suppression of the senescence-associated secretory phenotype.
Lim JS; Lee DY; Kim HS; Park SC; Park JT; Kim HS; Oh WK; Cho KA
Mech Ageing Dev; 2020 Dec; 192():111355. PubMed ID: 32941937
[TBL] [Abstract][Full Text] [Related]
7. S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α.
Su Y; Xu C; Sun Z; Liang Y; Li G; Tong T; Chen J
Aging (Albany NY); 2019 Jan; 11(2):549-572. PubMed ID: 30670674
[TBL] [Abstract][Full Text] [Related]
8. Redox control of the senescence regulator interleukin-1α and the secretory phenotype.
McCarthy DA; Clark RR; Bartling TR; Trebak M; Melendez JA
J Biol Chem; 2013 Nov; 288(45):32149-32159. PubMed ID: 24062309
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
10. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.
Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L
Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534
[TBL] [Abstract][Full Text] [Related]
11. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J
PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174
[TBL] [Abstract][Full Text] [Related]
12. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.
Wiley CD; Schaum N; Alimirah F; Lopez-Dominguez JA; Orjalo AV; Scott G; Desprez PY; Benz C; Davalos AR; Campisi J
Sci Rep; 2018 Feb; 8(1):2410. PubMed ID: 29402901
[TBL] [Abstract][Full Text] [Related]
14. [Induction of robust senescence-associated secretory phenotype in mouse NIH-3T3 cells by mitomycin C].
Huang WX; Guo XX; Peng ZZ; Weng CL; Huang CY; Shi BY; Yang J; Liao XX; Li XY; Zheng HL; Liu XG; Sun XR
Sheng Li Xue Bao; 2017 Feb; 69(1):33-40. PubMed ID: 28217805
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
Lau L; Porciuncula A; Yu A; Iwakura Y; David G
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin alleviates cellular senescence through oxytocin receptor-mediated extracellular signal-regulated kinase/Nrf2 signalling.
Cho SY; Kim AY; Kim J; Choi DH; Son ED; Shin DW
Br J Dermatol; 2019 Dec; 181(6):1216-1225. PubMed ID: 30801661
[TBL] [Abstract][Full Text] [Related]
18. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
19. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
Freund A; Patil CK; Campisi J
EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
[TBL] [Abstract][Full Text] [Related]
20. The senescent bystander effect is caused by ROS-activated NF-κB signalling.
Nelson G; Kucheryavenko O; Wordsworth J; von Zglinicki T
Mech Ageing Dev; 2018 Mar; 170():30-36. PubMed ID: 28837845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
